Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hansson, G.K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hansson, G.K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


The stabilized plaque: will the dream come true?

G.K. Hansson*

Centre for Molecular Medicine and Department of Medicine, Karolinska Hospital, Stockholm, Sweden

* Correspondence: Göran K. Hansson, Centre for Molecular Medicine and Department of Medicine, Karolinska Hospital, SE-17176, Stockholm, Sweden.

References

  1. Libby P, Hansson GK, Pober JS. Atherogenesis and inflammation. Chien KR. Molecular Basis of Cardiovascular Disease. Philadelphia: WB Saunders; 1999. p. 349–366
  2. Hansson GK, Nilsson J. Pathogenesis of atherosclerosis. Crawford MH, DiMarco JP. Cardiology. London: Mosby; 2000. p. 1.1–1.12
  3. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131–138[Abstract/Free Full Text]
  4. Stary HC, Chandler B, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on vascular lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462–2478[Abstract/Free Full Text]
  5. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92:1355–1374[Abstract/Free Full Text]
  6. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984;310:1137–1140[Abstract]
  7. Davies ML. Stability and instability: two faces of coronary atherosclerosis. Circulation. 1996;94:2013–2020[Free Full Text]
  8. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657–671[Free Full Text]
  9. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36–44[Abstract/Free Full Text]
  10. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 1995;92:1084–1088[Abstract/Free Full Text]
  11. Maseri A. Inflammation, atherosclerosis, and ischemic events—exploring the hidden side of the moon. N Engl J Med. 1997;336:1014–1016[Free Full Text]
  12. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844–2850[Free Full Text]
  13. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493–2503
  14. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscl Thromb. 1991;11:1223–1230[Abstract/Free Full Text]
  15. Hansson GK, Hellstrand M, Rymo L, Rubbia L, Gabbiani G. Interferon-{gamma} inhibits both proliferation and expression of differentiation-specific {alpha}-smooth muscle actin in arterial smooth muscle cells. J Exp Med. 1989;170:1595–1608[Abstract/Free Full Text]
  16. Geng Y-J, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-{gamma}, tumor necrosis factor-{alpha} and Interleukin-1ß. Arterioscl Thromb Vasc Biol. 1996;16:19–27[Abstract/Free Full Text]
  17. Emeis JJ, Kooistra T. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med. 1986;163:1260–1266[Abstract/Free Full Text]
  18. Niedbala MJ, Stein Picarella M. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by {gamma}-interferon. Blood. 1992;79:678–687[Abstract/Free Full Text]
  19. Arnman V, Stemme S, Rymo L, Risberg B. Interferon-{gamma} modulates the fibrinolytic response in cultured human endothelial cells. Thromb Res. 1995;77:431–440[CrossRef][Web of Science][Medline]
  20. Gallicchio M, Hufnagl P, Wojta J, Tipping P. IFN-{gamma} inhibits thrombin- and endotoxin-induced plasminogen activator inhibitor type 1 in human endothelial cells. J Immunol. 1996;157:2610–2617[Abstract]
  21. Dichtl W, Stiko A, Eriksson P, et al. Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vase Biol. 1999;19:3025–3032
  22. Carmeliet P, Ng YS, Nuyens D, et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nature Med. 1999;5:
  23. Caligiuri G, Lévy B, Pernow J, Thorén P, Hansson GK. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci USA. 1999. p. 6920–6924
  24. Saikku P. Chlamydia pneumoniae and atherosclerosis—an update. Scand J Infect Dis Suppl. 1997;104:53–56[Medline]
  25. Cercek B, Yamashita M, Dimayuga P, et al. Arterial smooth muscle cells transiently mobilize nuclear factor -{kappa}B and express vascular adhesion molecule-1 after balloon injury in rats. Atherosclerosis. 1977;131:59–66
  26. Dichtl W, Nilsson L, Goncalves I, et al. Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells. Circ Res. 1999;84:1085–1094[Abstract/Free Full Text]
  27. Yan Z-q, Sirsjö A, Bochaton-Piallat M-L, Gabbiani G, Hansson GK. Augmented expression of inducible nitric oxide synthase in vascular smooth muscle cells during aging depends on enhanced NF-{varkappa}B activation. Arterioscl Thromb Vasc Biol. 1999;: (in press)
  28. Baldwin AS. The NF-kB and IkB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–681[CrossRef][Web of Science][Medline]
  29. Erl W, Hansson GK, de Martin R, Draude G, Weber KSC, Weber C. Nuclear factor-{kappa}B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res. 1999;84:668–677[Abstract/Free Full Text]
  30. Wahl SM, Hunt DA, Wong HL, et al. Transforming growth factor-ß is a potent immunosuppressive agent that inhibits IL-1 dependent lymphocyte proliferation. J Immunol. 1988;140:3026–3032[Abstract]
  31. Varga J, Olsen A, Herbal J, Constantine G, Rosenbloom J, Jimenez SA. Interferon-gamma reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-beta in normal human fibroblasts. Eur J Clin Invest. 1990;20:487–493[Web of Science][Medline]
  32. Battegay EJ, Raines EW, Seifert RA, Bowen PD, Ross R. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 1990;63:515–524[CrossRef][Web of Science][Medline]
  33. Stouffer GA, Owens GK. TGF-ß promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J Clin Invest. 1994;93:2048–2055
  34. Kulkarni AB, Huh CG, Becker D, et al. Transforming growth factor ß1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA. 1993. p. 770–774
  35. Gorelik L, Flavell RA. Abrogation of TGFß signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity. 2000;12:171–181[CrossRef][Web of Science][Medline]
  36. Borkowski P, Robinson MJ, Kusiak JW, Borkowski A, Brathwaite C, Mergner WJ. Studies on TGF-beta 1 gene expression in the intima of the human aorta in regions with high and low probability of developing atherosclerotic lesions. Modern Pathol. 1995;8:478–482[Web of Science][Medline]
  37. McCaffrey TA, Du B, Consigh S, et al. Genomic instability in the type II TGF-ß1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest. 1997;100:2182–2188[Web of Science][Medline]
  38. Frostegård J, Ulfgren AK, Nyberg P, et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Thl) and macrophage-stimulating cytokines. Atherosclerosis. 1999;145:33–43[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hansson, G.K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hansson, G.K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?